Quantum Biopharma (QNTM) Short-term Investments (2019 - 2026)
Quantum Biopharma recorded quarterly Short-term Investments of $222906.0 in Q1 2026, down 51.45% quarter-over-quarter from $459080.0 in Q4 2025, and up 968.17% year-over-year from $20868.0 in Q1 2025.
Quantum Biopharma's Short-term Investments history runs 8 years deep, the most recent figure standing at $222906.0 for Q1 2026.
- In Q1 2026, Short-term Investments rose 968.17% year-over-year to $222906.0; the TTM figure through Mar 2026 stood at $222906.0 (up 968.17% YoY), while the FY2025 annual figure was $459080.0, down 61.82% from the prior year.
- Short-term Investments came in at $222906.0 for Q1 2026 at Quantum Biopharma, down from $459080.0 in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $3.5 million in Q3 2024 to a low of -$744500.0 in Q3 2023.
- A 5-year average of $421665.5 and a median of $222906.0 in 2026 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments slumped 12182.12% in 2023 and jumped 968.17% in 2026, its largest moves.
- Quantum Biopharma's Short-term Investments stood at $6162.0 in 2022, then plunged by 12182.12% to -$744500.0 in 2023, then soared by 261.5% to $1.2 million in 2024, then slumped by 61.82% to $459080.0 in 2025, then slumped by 51.45% to $222906.0 in 2026.
- According to Business Quant data, Short-term Investments over the past three periods registered $222906.0, $459080.0, and -$462325.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 222,906.00 |
| Dec 31, 2025 | 459,080.00 |
| Sep 30, 2025 | -462,325.00 |
| Mar 31, 2025 | 20,868.00 |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | -3.49 Mn |
| Jun 30, 2024 | 21,918.00 |
| Mar 31, 2024 | -22,140.00 |
| Sep 30, 2023 | 739,600.00 |
| Jun 30, 2023 | 550,283.00 |
| Mar 31, 2023 | 650,334.00 |
| Sep 30, 2022 | 365,092.00 |
| Jun 30, 2022 | -6,162.00 |
| Mar 31, 2022 | 540,203.00 |
| Dec 31, 2021 | 158,036.00 |
| Sep 30, 2021 | 1.50 Mn |
| Jun 30, 2021 | 2.26 Mn |
| Mar 31, 2021 | 2.64 Mn |
| Sep 30, 2020 | 1.20 Mn |
| Dec 31, 2019 | 8.92 Mn |